Simultaneous multivessel percutaneous coronary intervention and transfemoral transcatheter aortic valve implantation with ACURATE neo

Abstract

Coronary artery disease (CAD), due to common risk factors, often accompanies aortic stenosis (AS) [1]. CAD occurs in 50–75% of patients undergoing transcatheter aortic valve implantation (TAVI) [1]. However, there are no data on the necessity and the extent of revascularization in CAD patients referred for TAVI. According to the ESC/EACTS guidelines for myocardial revascularization published in 2018, percutaneous coronary intervention (PCI) should be considered in patients with stenoses > 70% in proximal segments of coronary arteries, undergoing TAVI [2]. Optimal timing (before, simultaneously or after TAVI) and the mode of revascularization have not yet been established [2].